CLAIRE CROMER: Open Payments
NPI 1649908666 · HICKORY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,486 in 79 payments from 23 companies in 2025. Trend: 2023 $33 · 2024 $191 · 2025 $1,486
Food & beverage: $1,486
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $392 |
| ABBVIE INC. | 10 | $157 |
| GlaxoSmithKline, LLC. | 5 | $103 |
| Novo Nordisk Inc | 6 | $102 |
| PFIZER INC. | 5 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $84 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| TOLMAR, INC. | 3 | $54 |
| Axsome Therapeutics, Inc. | 3 | $52 |
| Aimmune Therapeutics, Inc. | 3 | $49 |
Products named: FARXIGA, REXULTI, BREZTRI, TRELEGY ELLIPTA, UBRELVY, CAPLYTA, JATENZO, Symbravo.
Industry payments across NC — which companies pay providers there.
